Immunotherapy of cryptosporidiosis in immunodeficient animal models.
Immunotherapy for persistent infection caused by Cryptosporidium parvum was attempted in two immunodeficient animal models. BALB/c Athymic (nude) mice were infected with two oral doses of 2 x 10(7) C. parvum oocysts, and subsequently treated with monoclonal antibody (MAb) 17.41 that neutralizes sporozoites and merozoites. Persistent infection was established in all exposed mice. Daily oral treatment with MAb 17.41 for 10 days significantly reduced (p less than 0.005) the number of C. parvum organisms observed by microscopic study of intestinal tracts of infected mice. Young horses with severe combined immunodeficiency (SCID) also developed persistent infection following oral exposure with 10(8) C. parvum oocysts. In contrast to nude mice, SCID foals exhibited diarrhea associated with oocyst shedding. Two foals were treated orally with MAb 18.44 and immune serum, both of which neutralized C. parvum sporozoites and merozoites. Oocyst shedding patterns did not significantly differ from those in five SCID foals treated with nonimmune reagents. The results obtained indicate that SCID foals are a useful large animal model of clinical disease associated with persistent C. parvum infection, and that nude mice are a convenient animal model for testing therapeutic potential of antibodies in persistent cryptosporidial infection.
Perryman
L E
LE
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman 99164-7040.
Bjorneby
J M
JM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000913:Antibodies, Protozoan / Q000627:therapeutic use*; D003457:Cryptosporidiosis / Q000276:immunology / Q000628:therapy*; D004195:Disease Models, Animal; D006736:Horses; D016867:Immunocompromised Host; D007167:Immunotherapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude
D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan